PubMed · 10088357
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
H Sagara. 1999. [Cholera].. https://pubmed.ncbi.nlm.nih.gov/10088357/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
Several new spiro indoline-based heterocycles were synthesized by prior preparation of the 4-(2'-oxo-indol-3'-ylidene)-oxazol-5-one derivatives and subsequent reaction of the produced indol-3-ylidene based heterocycles with activated nitrile reagents. The obtained products were allowed to react with hydrazine hydrate in alcoholic basic to give the target compounds. Structure of these products was confirmed on the bases of elemental as well as spectral data. Representative compounds of the hitherto synthesized products were tested and evaluated as antimicrobial agents.
The solution structure of rifaximin and its derivative rifaximin OR (open ring) was determined by combining NMR experimental results, theoretical simulation of two-dimensional NMR spectra by complete relaxation matrix analysis (corma), and molecular dynamics calculations. In this study the structural rearrangements due to the opening of the aliphatic chain of rifaximin after the reduction process to form rifaximin OR were investigated. Close spatial proximity of CH(3)(14) and H28b protons detected by 2D-ROESY spectrum of rifaximin OR, which was not present in rifaximin and the down-field shift of CH(3)(34) protons in rifaximin OR (1)H spectrum were crucial to understand the structural modifications, which occurred within the system. The aliphatic chain of rifaximin OR was found to be no longer symmetrical with respect to the aromatic moiety. Although no dramatic structural rearrangements were detected, the aliphatic chain moved toward CH(3)(14), causing a reduction of the aromatic shielding contribution in particular on CH(3)(34).
OBJECTIVES: Despite a 97% reduction in clinical sulphonamide usage, the prevalence of sulphonamide resistance among Escherichia coli has remained constant in the UK. Genetic linkage of sulphonamide resistance to other resistances is thought important for this maintenance, but the finding also implies that sulphonamide resistance exerts little fitness cost. To test this hypothesis, we examined the fitness impact of four naturally occurring sul2-coding plasmids upon their hosts. METHODS: The fitness impact of the plasmids upon E. coli was determined by pairwise growth competition in a minimal medium. The DNA sequence of plasmid p9123 was obtained by primer walking and PCR. RESULTS: Three of the four sul2-coding plasmids studied imposed fitness costs on their hosts. The fourth plasmid, a 6.2 kb resistance element carrying sul2, strA and strB designated p9123, conferred a 4% fitness advantage upon its original clinical host and also on E. coli K12 JM109. The complete sequence of p9123 revealed eight open reading frames, including five of unknown function. There was no obvious gene to which the fitness advantage might be attributed. CONCLUSIONS: The novel finding that p9123 can improve host fitness may explain why this plasmid and its close relatives are so widespread among enteric bacteria. In addition to other factors such as co-selection of sulphonamide resistance by other agents, the fitness advantage conferred by plasmids such as p9123 may have contributed to the maintenance of sulphonamide resistance in the UK in the absence of clinical selection pressure. These data indicate that once antibiotic resistance has been established on mobile genetic elements, it may be difficult to eliminate.